Related Experiment Video
Updated: May 14, 2026
09:09
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Two-component covalent inhibitor
Evan M Cornett1, Yulia V Gerasimova, Dmitry M Kolpashchikov
1Chemistry Department, University of Central Florida, 4000 Central Florida Blvd, Orlando, FL 32816, USA.
Bioorganic & Medicinal Chemistry
|February 16, 2013
Summary
A novel two-component covalent inhibitor (TCCI) approach enhances specificity and potency for targeting biopolymers. This method uses two analogs that bind adjacent sites, facilitating targeted covalent damage, even in complex biological systems.
Area of Science:
- Biochemistry
- Chemical Biology
- Drug Design
Background:
- Covalent inhibitors offer high potency but face challenges in rational design and specificity.
- Existing single-component inhibitors can lack specificity in complex biological environments.
Purpose of the Study:
- To introduce and validate a general concept for constructing two-component covalent inhibitors (TCCI).
- To demonstrate the effectiveness of TCCI in achieving specific and potent biopolymer inactivation.
Main Methods:
- Developed a TCCI strategy utilizing two ligand analogs with pre-reactive groups.
- Employed light-activated pre-reactive groups for targeted covalent modification.
- Assessed the inactivation of a DNA polymerase in the presence of a non-target protein.
Main Results:
- The TCCI approach successfully brought pre-reactive groups into proximity for covalent damage.
- TCCI demonstrated robust efficiency, unaffected by the presence of a non-target protein.
- Traditional single-component inhibitors showed significantly reduced efficacy in the same complex system.
Conclusions:
- The TCCI strategy offers a significant advancement in designing potent and specific covalent inhibitors.
- TCCI exhibits superior performance in complex multi-component biological systems compared to traditional inhibitors.
- This approach holds promise for targeted inactivation of various biopolymers with enhanced precision.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...